Related Experiment Video
Updated: Sep 18, 2025

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
Harnessing R-loop dynamics: Challenging cancer therapy resistance
Michele Giaquinto1, Alessandro Framarini1, Andrea Parlante1
1Dipartimento di Scienze della Vita, Università degli Studi di Trieste, Via E. Weiss 2, Trieste 34127, Italy.
R-loops are DNA:RNA structures crucial for cellular processes. Dysregulated R-loops in cancer can lead to genome instability, impacting therapy resistance and treatment strategies.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- R-loops are DNA:RNA hybrid structures critical for gene regulation and DNA replication.
- Proper R-loop regulation is essential for maintaining genome stability.
- Aberrant R-loop accumulation is a hallmark of cancer cells, linked to oncogene and tumor suppressor gene mutations.
Purpose of the Study:
- To review the role of R-loops in cancer biology.
- To discuss R-loop regulators in cancer cells.
- To explore therapeutic strategies targeting R-loops and resistance mechanisms.
Main Methods:
- Literature review of R-loop functions in normal and cancer cells.
- Analysis of R-loop involvement in DNA damage, replication, and epigenetic regulation.
- Examination of R-loop-targeting cancer therapies and resistance pathways.
Main Results:
- Unscheduled R-loops induce DNA damage and compromise genome stability.
- Altered R-loop levels in cancer disrupt physiological processes and drive genomic instability.
- Antineoplastic drugs targeting R-loops can exacerbate instability but also induce cell death.
Conclusions:
- R-loops are key players in cancer development and progression.
- Therapeutic strategies aimed at modulating R-loops show promise in cancer treatment.
- Understanding R-loop dynamics is crucial for overcoming therapy resistance in cancer.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Related Concept Videos
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...